Sol-Gel Technologies Ltd.
Nasdaq · Healthcare · Pharmaceutical Preparations · Ness Ziona
SLGL chart
What traders are saying about $SLGL
Latest postsSol-Gel Technologies Ltd. news
- A fund reports 166,473 shares in Sol-Gel Technologies (SLGL), exceeding 5% ownership.
Stock Titan ·
- New Strong Buy Stocks for October 16th
Yahoo Finance ·
- Sol-Gel Eyes 2028 Launch as SGT-610 Nears Pivotal Gorlin Syndrome Data
marketbeat.com ·
- SolGel Technologies (SLGL) Upgraded to Buy: Here's Why
Yahoo Finance ·
- Sol-Gel Technologies to Host KOL Investor Day for SGT-610 on October 14, 2026
Yahoo Finance ·
- SolGel Technologies (SLGL) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
Yahoo Finance ·
- Sol-Gel Technologies Announces Last Patient Last Visit in Pivotal Phase 3 Clinical Trial of SGT-610 in Gorlin Syndrome
Yahoo Finance ·
- Sol-Gel Reports Second Quarter 2026 Financial Results and Provides Corporate Updates
Yahoo Finance ·
- Metagenomi Therapeutics (MGX) Reports Q2 Loss, Lags Revenue Estimates
Yahoo Finance ·
- Bausch Health (BHC) Q2 Earnings and Revenues Beat Estimates
Yahoo Finance ·
- Sol-Gel Reports First Quarter 2026 Financial Results and Provides Corporate Updates
Yahoo Finance ·
- Sol-Gel Technologies Ltd. Announces Pricing of Oversubscribed Underwritten Offering
Yahoo Finance ·
Sol-Gel Technologies Ltd. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $19.4M | $11.5M | $1.6M | $3.9M |
| Net income | -$6.1M | -$10.6M | -$27.2M | -$14.9M |
| Diluted EPS | $-2.19 | $-3.79 | $-10.01 | $-0.65 |
| Total assets (year end) | $29.9M | $35.8M | $45.3M | $46.6M |
| Cash and equivalents (year end) | $11.0M | $19.5M | $7.5M | $12.4M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Sol-Gel Technologies Ltd.
- Ticker
- SLGL (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Ness Ziona
- Incorporated in
- Israel
- Fiscal year end
- December 31
- SEC CIK
- 1684693
Frequently asked questions
What exchange is Sol-Gel Technologies Ltd. listed on?
Sol-Gel Technologies Ltd. trades on the Nasdaq under the ticker symbol SLGL.
What industry is Sol-Gel Technologies Ltd. in?
Sol-Gel Technologies Ltd. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Sol-Gel Technologies Ltd. headquartered?
Sol-Gel Technologies Ltd.'s business address on file with the SEC is in Ness Ziona.
When does Sol-Gel Technologies Ltd.'s fiscal year end?
Sol-Gel Technologies Ltd.'s fiscal year ends on December 31.
How much revenue did Sol-Gel Technologies Ltd. report?
Sol-Gel Technologies Ltd. reported $19.4M in revenue for calendar year 2025, according to its SEC filings.